Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica
NCT ID: NCT02151045
Last Updated: 2015-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
112 participants
INTERVENTIONAL
2012-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Plane Block vs Transforaminal Epidural Injection
NCT04212845
Evaluation of Dermatomal Distribution in the Erector Spinae Plane (ESP) Block
NCT03831581
Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.
NCT01694134
Involvement of Transverso-sacral- Neo- Articulations or of Transverso-iliac Articulations in Chronic Lumbago
NCT01206699
Efficacy and Safety of IntraSPINE® Associated with Discectomy in the Treatment of Lumbar Disc Herniation.
NCT03752671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non target epidural infiltration at L3-L4 stage
In this control arm, there are patients with a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control.
These patients must have a discal hernia confirmed by scanner or RMI
Non target epidural infiltration done at L3-L4 stage
For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control
Epidural infiltration on contact of disco radicular conflict
In this experimental arm, there are patients with an epidural infiltration of corticoids done in lateral on contact of disco radicular conflict on scan control.
These patients must have a discal hernia confirmed by scanner or RMI
Epidural infiltration on contact of disco radicular conflict
For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non target epidural infiltration done at L3-L4 stage
For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control
Epidural infiltration on contact of disco radicular conflict
For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged from 18 to 65 years
* Affiliated or benefit from an insurance regimen
* Patient with a sciatic answering to the definition
* Discal sciatica more than 15 days and less than 6 months
* Discal hernia (scan or RMI)
* Negative BHCG and normal coagulation parameters
Exclusion Criteria
* Spinal infiltration of corticoids in 30 days before inclusion
* Iode allergy
* Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA
* Motor loss \< 4 (muscular testing)
* Sphincter disorder (cauda equida syndrome)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric ET THOMAS, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, , France
CHU Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8708
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.